Sejong Medical Extraordinary General Meeting Approves Articles Amendment and New Director Appointments, No Significant Impact on Shareholder Value

Sejong Medical held an extraordinary general meeting on June 30, 2026, approving all agenda items including amendments to the articles of incorporation and appointment of inside directors and auditor.
The articles amendment was passed as a special resolution, and newly appointed inside directors are Shin Yong-seop and Yoon Hee-jung, with Jo Hyun-ju as auditor, each serving a three-year term.
This shareholder meeting did not involve any capital changes or dividend-related matters, thus no direct impact on existing shareholder value.
[AI Summary]Sejong Medical completed a governance restructuring via a one-time extraordinary meeting, but with no change in shares outstanding or capital, the impact on stock price is neutral. The future influence of new directors on performance requires continuous monitoring.